*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Formulation and Evaluation of Intranasal Microemulsion of Entacapone For Treatment of Parkinsonism

Author: ASHISH P.GORLE, RUTUJA S.SHENDE, JAYESH A.MAHIRRAO
Abstract: In the present study, the developed Entacapone (ENT) loaded microemulsion (ME) prone to increase the solubility of ENT by components of microemulsion including formulation concern, characterization, mucosal diffusion, stability and nasal ciliotoxicity of Entacapone microemulsion (EME). For nasal delivery of Entacapone, a challenge existing in formulation development is the solubilization of poorly water-soluble Entacapone. The purpose of this study was to improve the solubility and to enhance the brain uptake of Entacapone through an O/W microemulsion, with suitable intranasal delivery. The optimal microemulsion formulation consisted of Capmul MCM oil, Kolliphor EL: Transcutol HP (1:1) and water, with a maximum solubility of Entacapone and no ciliotoxicity, was developed and characterized. EME was characterized for % Transmittance, pH, viscosity, globule size, zeta potential, TEM, drug content with In-vitro release studies and Ex-vivo diffusion studies using Standard Franz Diffusion cell. The optimized microemulsion was found to be stable and transparent with average globule size 139.6 nm, PDI 0.272 and without showing any ciliotoxicity during its histopathological evaluation on goat nasal mucosa. The formulated Entacapone-loaded microemulsion was exhibited stable over period of 3 mo at room temperature, refrigeration temperature and elevated room temperature conditions.
Keyword: Entacapone, Intranasal Microemulsion, Ternary phase Diagram, Ex vivo diffusion
DOI: https://doi.org/10.31838/ijpr/2022.14.04.002
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free